Clinical Trials Browser

Phase 2 × Laryngeal Neoplasms × sargramostim × Clear all

NCT00004256 2013-11-06

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

Phase 2 Completed

Head and Neck Neoplasms, Laryngeal Neoplasms, Radiation Injuries